
About aflo
aflo™ will teach you how to inhale your medicines correctly and aggregate your inhalation data with air quality and viral data to help you to manage your condition.
Supported by funding from Innovate UK, CoFund, Ulster University and private investors, we have co-designed and built a hyper-personalised ‘smart inhaler’ for improved self management & quantified remote monitoring.
Meet our people
Dr Susan Kelly
CEO and Co-founder
Susan brings over fifteen years experience in Market Access/ Managed Entry for new medicines in the UK healthcare sector. Prior to forming Respiratory Analytics in 2019, to develop aflo™, she held a series of roles focused on the development of digital respiratory solutions.
Prof Liam McDaid
R&D Head and Co-founder
Liam cofounded Respiratory Analytics and leads the machine learning algorithm development, training, testing and deployment for aflo™
Dr Martin Kelly
Clinical Lead
Dr Martin Kelly worked in Christchurch, New Zealand before becoming a consultant respiratory physician at Altnagelvin Hospital in 2004. Martin works on a number of EU wide asthma and COPD studies and has expertise in inhaler device technology.